China Aoxing Pharmaceutical Company reported that it has completed the registration trial of Codeine Phosphate, an oral solution that treats acute moderate to severe cough. The company plans to announce top-line results from the trial by the end of Q3 of 2009, and it hope to launch its codeine product in China in 2010, assuming positive trial results. More details..

Stock symbol: (NSDQBB: CAXG)